Morgan Stanley has increased its investment rating on insurer Marsh & McLennan. From “equal weight” to “overweight.”
An analyst reported that the company’s stock price decline has been overdone given Marsh & McLennan’s variety of earnings mix, which includes profits from its fast-growing insurance brokerage segment.
According to the analyst, MMC is expected to generate $1.3 billion for free cash flow during the year.
Was this article valuable?
Here are more articles you may enjoy.
Allstate Sued by Oklahoma for Alleged Scheme to Underpay Claims 
Developer Downplays Structural Concerns at ‘Unstable’ Midtown Manhattan Tower 
Merger Suits Stall Under DOJ Boss Who Opposes Blocking Deals 
Clash of Florida Titans Pits Powerful Tribe Against Homebuilder Lennar 
